JC2-24050-48206
3 vaccinations
8 coded responses
30 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 604 / IL
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Registered dependents
7VP-26169-25090
Child or adolescent in my care · Female · 2021-11-08
UKU-10538-02373
Child or adolescent in my care · Female · 2021-11-08
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Chills, Headache, DiarrheaAdult check-in
- 2021-03-10
- 2021-03-13
- 2021-03-14
- 2021-03-17
-
2021-03-22
Survey response — day 14, dose 1MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Strong headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
-
2021-04-05
Dose 2 — Pfizer-BioNTech
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body achesAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-08
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
-
2021-05-11
Survey response — day 35, dose 2MedDRA: Dyspnoea, Inhalation therapy — Feeling: GoodFree text: Needing inhaler more for breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-19
-
2021-07-05
Survey response — 3 months, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: Changes in menstrual cycleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-04
-
2021-10-11
Dose 3 — Pfizer-BioNTech
-
2021-10-14
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Pruritus — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolFree text: General itching, swollen lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Survey response — days 1–6 daily, dose 3MedDRA: Neck pain — Feeling: Fair · Site: Swelling, Itching · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Neck painMedDRA releases: 2024-11 · check-in free text available
-
2021-10-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-10-18
- 2021-10-25
-
2021-11-01
Survey response — day 21, dose 3MedDRA: Menstrual disorder — Feeling: FairFree text: Changes in menstrual cycleMedDRA releases: 2024-11 · check-in free text available
- 2021-11-08
-
2021-11-24
Survey response — day 42, dose 3MedDRA: Cough, Headache, Nausea, Respiratory tract congestion — Feeling: Good · Be unable to work or attend schoolFree text: Cough, congestion, headache, slight nauseaMedDRA releases: 2024-11 · check-in free text available
-
2022-04-13
Survey response — 6 months, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-04-13
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-21
- 2022-10-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-04-05 | Pfizer-BioNTech | |
| 3 | 2021-10-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-13 | Unsuccessful |
Free text
Release 6 — day 14, dose 1
Symptoms: Strong headaches
Release 8 — day 35, dose 2
Symptoms: Needing inhaler more for breathing
Release 9 — 3 months, dose 2
Symptoms: Changes in menstrual cycle
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): General itching, swollen lymph nodes
Systemic reaction (other): Neck pain
Release 10 — day 21, dose 3
Symptoms: Changes in menstrual cycle
Release 10 — day 42, dose 3
Symptoms: Cough, congestion, headache, slight nausea
Release 11 — 6 months, dose 3
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Inhalation therapy | ✓ | ✓ | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Neck pain | · | · | ✓ |
| SRO | Pruritus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release